• Privacy Policy
  • Terms Of Service
  • Facebook
  • Twitter
  • LinkedIn
  • Instagram
Forex trading, free forex education | Forex.ca

 

  • Home
  • Forex News
  • Stock News
  • For Beginners
  • Market Analysis
  • Trading Strategies
  • Real Time Stock Update
  • Shop
News Ticker
  • [ September 30, 2025 ] Apellis Pharmaceuticals: Maintaining "Buy" Rating With Continued EMPAVELI Expansions Beyond PNH And C3G-Disorders Stock News
  • [ September 30, 2025 ] Virtus Newfleet Multi-Sector Short Term Bond Fund Q2 2025 Commentary Stock News
  • [ September 30, 2025 ] Tesla (TSLA) Share Price Rises Ahead of Earnings Report Forex News
  • [ September 29, 2025 ] Accenture: The Best Way To Play AI's Next Phase Stock News
  • [ September 29, 2025 ] Growth & Total Return Weekly Chat Stock News
Home2022

Year: 2022

Stock News

India’s largest multiplex operators to merge, creating cinema giant By Reuters

March 27, 2022 admin 0

© Reuters. FILE PHOTO: A worker wearing protective gear sprays disinfectant inside an empty PVR multiplex that was closed following the outbreak of the coronavirus disease (COVID-19), in New Delhi, India July 31, 2020. REUTERS/Adnan […]

Stock News

2nd vaccine booster significantly lowers COVID death rate By Reuters

March 27, 2022 admin 0

© Reuters. FILE PHOTO: 89-year-old Yodit Ben Ari receives a fourth dose of the coronavirus disease (COVID-19) vaccine following a vaccination party after Israel approved a second booster shot for the immunocompromised, people over 60 […]

Stock News

Week In Review: Nuance In-Licenses RSV Vaccine In $225 Million Deal

March 27, 2022 admin 0

Morsa Images/DigitalVision via Getty Images Deals and Financings Shanghai Nuance Pharma in-licensed China and Southeast Asia rights to a respiratory syncytial virus (RSV) vaccine from Copenhagen’s Bavarian Nordic in a $225 million deal (see story). […]

Posts navigation

« 1 … 24,200 24,201 24,202 … 25,381 »

For Beginners


Categories

  • Forex News
  • Stock News
No Picture
Stock News

Apellis Pharmaceuticals: Maintaining "Buy" Rating With Continued EMPAVELI Expansions Beyond PNH And C3G-Disorders

September 30, 2025 0

Apellis Pharmaceuticals: Maintaining "Buy" Rating With Continued EMPAVELI Expansions Beyond PNH And C3G-Disorders

Stock News

Virtus Newfleet Multi-Sector Short Term Bond Fund Q2 2025 Commentary

September 30, 2025 0

Follow Summary The second quarter of 2025 was defined by several key policies from the new Trump administration, including tariffs/trade, immigration, and taxes. The fund returned 1.88% in the second quarter versus the ICE BoA […]

Latest news
  • Tesla (TSLA) Share Price Rises Ahead of Earnings Report
    September 30, 2025 0
  • Nikkei 225 Rises Following Resignation of Prime Minister Shigeru Ishiba
    September 8, 2025 0
Random News
  • Baidu: AI Boom At Mind Boggling Valuation (NASDAQ:BIDU)
    April 21, 2024 0
  • SSR Mining: Approaching A Low-Risk Buy Zone (NASDAQ:SSRM)
    October 13, 2022 0
  • ZIM Integrated: Ridiculously Cheap Valuation Implies Bargain Opportunity (NYSE:ZIM)
    August 17, 2022 0
Email Inquiries to: warp1@sympatico.ca
  • No Picture
    Apellis Pharmaceuticals: Maintaining "Buy" Rating With Continued EMPAVELI Expansions Beyond PNH And C3G-Disorders
    September 30, 2025 0
  • Virtus Newfleet Multi-Sector Short Term Bond Fund Q2 2025 Commentary
    September 30, 2025 0
Pages
  • Contact Us
  • Home
  • Privacy Policy
  • Real Time Stock Update
  • Shop
  • Terms Of Service

© Copyright 2020-2023 Forex.ca

Please note that foreign exchange and other leveraged trading involves significant risk of loss. It is not suitable for all investors and you should make sure you understand the risks involved, seeking independent advice if necessary.